Literature DB >> 15853431

Meningococcal vaccination: cui bono?

Thomas D Szucs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15853431     DOI： 10.2165/00019053-200523040-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Vaccination programme for group C meningococcal infection is launched.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1999-07-23

2.  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2002-01-15

Review 3.  [Meningococcal disease. new prevention strategies].

Authors:  J A Soult Rubio; M Muñoz Sáez; J D López Castilla
Journal:  An Esp Pediatr       Date:  2001-01

Review 4.  Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.

Authors:  Mark A Miller; Cathryn K Shahab
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccine strategies.

Authors:  H Jaccard Ruedin; S Ess; H P Zimmermann; T Szucs
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.